Germantown, MD · Founded 2019 · Privately Held (backing)
Operator of a biotechnology company intended to develop and deliver life-changing medicines for cancer and inflammatory diseases. DEKA Biosciences is based in Germantown, MD and was founded in 2019. It was valued at $36 million at its early-stage round in Feb 2023, the last priced event on record. It has raised $104 million across 2 recorded rounds; the latest was a $29.9 million early-stage round in Feb 2023.
PMV mark · valuation
$36.0M
Oct 2026
Priced at
its early-stage round
Feb 2023
Total raised
$104.2M
Last round
Early Stage VC
Feb 2023
Team — not yet on record
No current team members for DEKA Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DEKA Biosciences with a free account
·Watch DEKA Biosciences: the Monday email on marks, rounds and moves
